UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 2016
AMERICAN BIO MEDICA CORPORATION
(Exact name of registrant as specified in its charter)
| New York | 0-28666 | 14-1702188 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification Number) |
122 Smith Road, Kinderhook, NY 12106
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 518-758-8158
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| ITEM 5.07 | Submission of Matters to a Vote of Security Holders |
At the Annual Meeting of the Shareholders of the Company held on June 16, 2016 (the “Annual Meeting”), at the Company’s corporate offices in Kinderhook, New York, the following matters were voted upon.
PROPOSAL NUMBER 1 – ELECTION OF DIRECTORS
|
Total Shares in Attendance: |
24,590,622 |
Total Shares Outstanding (as of April 20, 2016):
27,271,408 | |||
| Percent of Shares Voted: | 90.2% | ||||
| Director | For | Percent | Withheld | Percent | Broker Non-Vote |
| Carl A. Florio | 10,883,892 | 97.7% | 258,484 | 2.3% | 13,448,246 |
PROPOSAL NUMBER 2 – RATIFICATION OF AUDITORS
|
Total Shares in Attendance: |
24,590,622 |
Total Shares Outstanding (as of April 20, 2016):
27,271,408 | ||||
| Percent of Shares Voted: | 90.2% | |||||
| For | Percent | Against | Percent | Abstain | Percent | Broker Non-Vote |
| 24,120,848 | 98.1% | 145,506 | 0.6% | 324,268 | 1.3% | 0 |
PROPOSAL No. 3 - non-binding advisory resolution regarding the compensation of the Company’s Named Executive Officers
|
Total Shares in Attendance: |
24,590,622 |
Total Shares Outstanding (as of April 20, 2016):
27,271,408 | ||||
| Percent of Shares Voted: | 90.2% | |||||
| For | Percent | Against | Percent | Abstain | Percent | Broker Non-Vote |
| 8,768,125 | 78.7% | 2,213,176 | 19.9% | 161,075 | 1.4% | 13,448,246 |
A description of the proposals can be found in the Company’s definitive proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on April 27, 2016.
The nominee for election to the Board of Directors was elected for a three-year term ending in 2019, or until his successor(s) is elected and duly qualified. In addition to the director elected at the Annual Meeting, Jean Neff, Diane J. Generous, Richard P. Koskey and Melissa A. Waterhouse continued their term of office after the Annual Meeting.
There were no other matters voted upon at the Annual Meeting other than the Proposals noted above.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMERICAN BIO MEDICA CORPORATION (Registrant) | |||
| By: | /s/ Melissa A. Waterhouse | ||
| Melissa A. Waterhouse Chief Executive Officer (Principal Executive Officer) Principal Financial Officer | |||
Dated: June 21, 2016